Diaceutics

DXRX · AIM · Health Care · mcap £172m · 203.0p

Beta Briefing, track record and signals & risks are not ready for Diaceutics yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 22 Sep 26 ↗

Revenue: £41.3m
Operating profit: −£794k
Net income: −£271k
Free cash flow: −£2.5m
Net cash: £8.1m
Market cap: £174m
EV / EBIT: –
FCF yield: −1.5%
Price / book: 4.5×

Latest half-year · H1 26 vs H1 25 results 22 Sep 26 ↗

Revenue: £17.5m
Operating profit: −£4.0m
Net income: −£2.8m
Cash from operations: £3.3m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

As reported Key figures

Income statement Balance sheet Cash flow

Annual Half-yearly

Every line as the company printed it in the results of each period, newest first. Italic = calculated (H2 = full year − first half). The column headings link to the announcements.

Latest report: H1 26 (six months to 30 Jun 26), published 22 Sep 26 · read the results ↗

	FY 25£000	FY 24£000
Revenue	38,437	32,158
Cost of sales	(6,958)	(3,888)
Gross profit	31,479	28,270
Administrative expenses	(31,691)	(30,742)
Other operating income	255	17
Operating profit/(loss)	43	(2,455)
Finance income	317	601
Finance costs	(58)	(54)
Profit/(loss) before tax	302	(1,908)
Income tax (charge)/credit	(205)	205
Profit/(loss) for the financial year	97	(1,703)
Basic earnings/(loss) per share	0.11	(2.02)
Diluted earnings/(loss) per share	0.11	(2.02)

	H1 26£000	H2 25£000	H1 25£000
Revenue	17,456	23,873	14,564
Cost of sales	(2,595)	(4,481)	(2,477)
Gross profit	14,861	19,392	12,087
Administrative expenses	(18,941)	(16,256)	(15,435)
Other operating income	64	86	169
Operating (loss)/profit	(4,016)	3,222	(3,179)
Finance Income	74	122	195
Finance costs	(26)	(29)	(29)
(Loss)/profit before tax	(3,968)	3,315	(3,013)
Income tax credit/(charge)	1,199	(817)	612
(Loss)/profit for the financial period	(2,769)	–	(2,401)

	Latest Jun 26£000	FY 25£000	FY 24£000
ASSETS
Non-current assets
Intangible assets	15,746	16,080	15,413
Right of use assets	2,027	1,108	1,026
Property, plant and equipment	493	556	652
Deferred tax asset	4,482	2,902	2,000
Total non-current assets	22,748	20,646	19,091
Current assets
Trade and other receivables	20,944	21,256	16,043
Income tax receivable	359	762	742
Cash and cash equivalents	8,102	7,344	12,744
Total current assets	29,405	29,362	29,529
TOTAL ASSETS	52,153	50,008	48,620
EQUITY AND LIABILITIES
Equity
Equity share capital	170	170	170
Treasury shares	(312)	(312)	(312)
Translation reserve	(843)	(980)	(626)
Profit and loss account	–	41,602	40,625
TOTAL EQUITY	–	40,480	39,857
Lease liability	–	882	907
Provision for dilapidation	–	95	91
Total non-current liabilities	–	977	998
Trade and other payables	–	8,254	7,611
Lease liability	–	270	153
Income tax liability	–	27	1
Total current liabilities	–	8,551	7,765
TOTAL LIABILITIES	–	9,528	8,763
TOTAL EQUITY AND LIABILITIES	–	50,008	48,620

	H1 26£000	H2 25£000	H1 25£000	H2 24£000
ASSETS
Non-current assets
Intangible assets	15,746	16,080	15,362	15,413
Right of use assets	2,027	1,108	1,090	1,026
Property, plant and equipment	493	556	621	652
Deferred tax asset	4,482	2,902	2,886	2,000
Total non-current assets	22,748	20,646	19,959	19,091
Current assets
Trade and other receivables	20,944	21,256	13,512	16,043
Income tax receivable	359	762	568	742
Cash and cash equivalents	8,102	7,344	10,384	12,744
Total current assets	29,405	29,362	24,464	29,529
TOTAL ASSETS	52,153	50,008	44,423	48,620
EQUITY AND LIABILITIES
Equity
Equity share capital	170	170	170	170
Treasury shares	(312)	(312)	(312)	(312)
Translation reserve	(843)	(980)	(1,266)	(626)
Profit and loss account	–	41,602	–	40,625
TOTAL EQUITY	–	40,480	–	39,857
Lease liability	–	882	–	907
Provision for dilapidation	–	95	–	91
Total non-current liabilities	–	977	–	998
Trade and other payables	–	8,254	–	7,611
Lease liability	–	270	–	153
Income tax liability	–	27	–	1
Total current liabilities	–	8,551	–	7,765
TOTAL LIABILITIES	–	9,528	–	8,763
TOTAL EQUITY AND LIABILITIES	–	50,008	–	48,620

	FY 25£000	FY 24£000
Operating activities
Profit/(loss) before tax	302	(1,908)
Net finance costs	(259)	(547)
Amortization of intangible assets	5,355	4,306
Impairment of intangible assets	-	87
Depreciation of right to use asset	291	154
Depreciation of property, plant and equipment	166	167
Research and development tax credits	(62)	-
Share-based payments	915	1,020
Increase in trade and other receivables	(5,151)	(4,676)
Increase in trade and other payables	643	3,374
Cash provided by operating activities	2,200	1,977
Tax paid	(1,021)	(1,326)
Net cash provided by operating activities	1,179	651
Investing activities
Purchase of intangible assets	(6,377)	(4,532)
Purchase of property, plant and equipment	(71)	(100)
Finance income interest received	317	601
Net cash used in investing activities	(6,131)	(4,031)
Cash flows from financing activities
Interest paid	-	(1)
Leasehold repayments	(333)	(199)
Issue of shares on exercise of a warrant	-	136
Net cash used in financing activities	(333)	(64)
Net decrease in cash and cash equivalents	(5,285)	(3,444)
Net foreign exchange loss	(115)	(479)
Cash and cash equivalents at 1 January	12,744	16,667
Cash and cash equivalents at 31 December	7,344	12,744

	H1 26£000	H2 25£000	H1 25£000
(Loss)/profit before tax	(3,968)	3,315	(3,013)
Net finance income	(48)	–	(164)
Amortization of intangible assets	3,118	2,861	2,494
Research and development tax credits	-	(62)	-
Depreciation of right to use asset	156	167	124
Depreciation of property, plant and equipment	84	83	83
Decrease/(increase) in trade and other receivables	1,178	–	3,863
Increase/(decrease) in trade and other payables	1,917	3,782	(3,139)
Share based payments	924	490	425
Cash generated from operations	3,361	–	673
Tax paid	(12)	(953)	(68)
Net cash inflow from operating activities	3,349	–	605
Investing activities
Purchase of intangible assets	(2,425)	(3,610)	(2,767)
Purchase of property, plant and equipment	(21)	(16)	(55)
Finance interest received	74	–	195
Net cash outflow from investing activities	(2,372)	–	(2,627)
Financing activities
Leasehold repayments	(179)	(192)	(141)
Net cash outflow from financing activities	(179)	–	(141)
Net increase/(decrease) in cash and cash equivalents	798	–	(2,163)
Net foreign exchange movements	(40)	–	(197)
Opening cash and cash equivalents	7,344	–	12,744
Closing cash and cash equivalents	8,102	–	10,384

	LTM Jun 26	FY 25	FY 24
Revenue to operating profit
Revenue	41.3	38.4	32.2
Gross profit	34.3	31.5	28.3
Adjusted EBITDA	8.6	7.6	4.2
EBITDA	5.7	5.9	2.3
Operating profit	(0.8)	0.0	(2.5)
Depreciation (owned assets)	0.2	0.2	0.2
Depreciation (right-of-use)	0.3	0.3	0.2
Amortisation	6.0	5.4	4.3
Share-based payments	2.4	1.9	1.0
Operating profit to net income
Finance costs	(0.1)	(0.1)	(0.1)
Profit before tax	(0.7)	0.3	(1.9)
Tax	0.4	(0.2)	0.2
Net income (owners)	(0.3)	0.1	(1.7)
Per share
EPS basic	(0.3p)	0.1p	(2.0p)
EPS diluted	(0.3p)	0.1p	(2.0p)

	H1 26	vs H1 25	H2 25	H1 25
Revenue to operating profit
Revenue	17.5	+20%	23.9	14.6
Gross profit	14.9	+23%	19.4	12.1
Adjusted EBITDA	1.1	n/m	7.5	0.1
EBITDA	(0.7)	n/m	6.3	(0.5)
Operating profit	(4.0)	n/m	3.2	(3.2)
Depreciation (owned assets)	0.1	n/m	0.1	0.1
Depreciation (right-of-use)	0.2	+26%	0.2	0.1
Amortisation	3.1	+25%	2.9	2.5
Share-based payments	0.9	+117%	1.5	0.4
Operating profit to net income
Finance costs	(0.0)	n/m	(0.0)	(0.0)
Profit before tax	(4.0)	n/m	3.3	(3.0)
Tax	1.2	+96%	(0.8)	0.6
Net income (owners)	(2.8)	n/m	2.5	(2.4)
Per share
EPS basic	(3.3p)	–	2.9p	(2.8p)
EPS diluted	(3.3p)	–	2.9p	(2.8p)

	LTM Jun 26	FY 25	FY 24
Operating activities
Cash from operations	3.9	1.2	0.7
Interest paid	–	0.0	(0.0)
Tax paid	(1.0)	(1.0)	(1.3)
Investing activities
Capex (PP&E)	(0.0)	(0.1)	(0.1)
Capex (intangibles)	(6.0)	(6.4)	(4.5)
Financing activities
Lease principal paid	(0.4)	(0.3)	(0.2)
Shares issued	–	0.0	0.1

	H1 26	vs H1 25	H2 25	H1 25
Operating activities
Cash from operations	3.3	+454%	0.6	0.6
Tax paid	(0.0)	n/m	(1.0)	(0.1)
Investing activities
Capex (PP&E)	(0.0)	n/m	(0.0)	(0.1)
Capex (intangibles)	(2.4)	−12%	(3.6)	(2.8)
Financing activities
Lease principal paid	(0.2)	+27%	(0.2)	(0.1)

	Latest Jun 26	FY 25	FY 24
Non-current assets
Other intangibles	15.7	16.1	15.4
Property, plant & equipment	0.5	0.6	0.7
Non-current assets	22.7	20.6	19.1
Current assets
Trade receivables	20.9	21.3	16.0
Cash	8.1	7.3	12.7
Current assets	29.4	29.4	29.5
Total assets	52.2	50.0	48.6
Current liabilities
Trade payables	11.2	8.3	7.6
Lease liabilities, current	0.3	0.3	0.2
Current liabilities	11.5	8.6	7.8
Non-current liabilities
Lease liabilities, non-current	1.8	0.9	0.9
Non-current liabilities	1.9	1.0	1.0
Total liabilities	13.4	9.5	8.8
Equity
Total equity	38.8	40.5	39.9
Net cash and other figures
Shares in issue	85.0m	84.9m	–
Order book	43.7	38.9	24.9

	H1 26	H2 25	H1 25	H2 24
Non-current assets
Other intangibles	15.7	16.1	15.4	15.4
Property, plant & equipment	0.5	0.6	0.6	0.7
Non-current assets	22.7	20.6	20.0	19.1
Current assets
Trade receivables	20.9	21.3	13.5	16.0
Cash	8.1	7.3	10.4	12.7
Current assets	29.4	29.4	24.5	29.5
Total assets	52.2	50.0	44.4	48.6
Current liabilities
Trade payables	11.2	8.3	6.0	7.6
Lease liabilities, current	0.3	0.3	0.2	0.2
Current liabilities	11.5	8.6	6.2	7.8
Non-current liabilities
Lease liabilities, non-current	1.8	0.9	0.9	0.9
Non-current liabilities	1.9	1.0	1.0	1.0
Total liabilities	13.4	9.5	7.2	8.8
Equity
Total equity	38.8	40.5	37.2	39.9
Net cash and other figures
Shares in issue	85.0m	84.9m	84.8m	–
Order book	43.7	38.9	31.7	24.9

Read automatically from each results announcement. Check the source before relying on a figure.

Company filings. Not investment advice.